Treatment with direct-acting antivirals appears to reduce the risk of death and liver cancer among patients with chronic hepatitis C virus (HCV), including those with cirrhosis, new data has shown.
Medscape Medical News
Original Article: Newer HCV Drugs Reduce Mortality, Liver Cancer Risk